Interview: Aaron Motsoaledi – Minister of Health, South Africa
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
Address: Ground Floor, Building 5, Tuscany Office Park, 6 Coombe Place, Rivonia, 2129, Johannesburg, South Africa
Tel: +2711 2345701/2
Web: http://accord-healthcare.com/
A wholly owned subsidiary and the marketing arm of Intas Pharmaceuticals Ltd., India Accord is engaged in all the licensing related activities and pharmaceutical product trading in various Therapeutic Segments in the regulatory markets. The company leverages the manufacturing support from INTAS.
Accord Healthcare has its global matrix spread to USA, UK, Spain, Canada, Australia & New Zealand, South Africa, Brazil, Mexico, Peru, Vietnam, and Kenya.
Accord is committed to maximise customer satisfaction by introducing innovative, quality products in the market.
Accord Healthcare South Africa specializing in Oncology products as well as having a basket of products in the following therapeutic areas:
Biologicals, Immunosuppression, Cardio Vascular, Central Nervous System, Anti-diabetic, Nausea, Osteoporosis, Autonomic, Respiratory, GIT, Ophthalmics and Dermatologicals.
Clonazepam
Mycophenolate Mofetil
Levetiracetam Tablets
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
The managing director of Southern Medical, Malan de Villiers illustrates the sheer diversity of the company’s current activities and portfolio within South Africa as a leading implant devices company, while…
Charl Louw, Vice President Africa and Middle East at Acelity discusses the challenges of a two-tiered health system for Acelity, the significance of South Africa for the company’s global portfolio…
The managing director of MC Pharma Group, Henk Krebs illustrates how MC Pharma’s new operating structure enables the group to better service its clients, and also highlights the role of…
Ansie Savrda of ERS (pty) ltd, highlights the important role that ERS plays in helping pharmaceutical companies to efficiently navigate South Africa and Africa’s regulatory environment through the company’s broad portfolio of regulatory…
The country manager of Roche Diagnostics SA, Rajen Bhimaraj highlights the current gaps in the country’s healthcare system and elaborates on how the company’s various community initiatives, such as AmpliCare…
The founder and managing director of LT Clinical Research, one of the first wholly black-owned South African CRO, reveals how South Africa is a very conducive environment for CROs, with…
The General Manager of Boehringer Ingelheim South Africa talks about changes that are required to the healthcare system, with far more government/private partnerships, helping to unlock the country´s potential, why…
CEO of the Clicks Group, David Kneale highlights the motivations behind groups involvement in the Public Health Enhancement Fund (PHEF), and also describe the key strategies that have allowed Clicks…
The General Manager of Abbott’s Established Pharmaceuticals Division in South Africa, Gauta Phillip Mavundla illustrates how he is building the division’s presence within the region after the spinoff of AbbVie,…
Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by Meiji and the importance of local partnerships for global success. Can…
The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He…
See our Cookie Privacy Policy Here
